Development of a Psychosocial Intervention to Reduce Post Traumatic Stress in Young Adult Survivo… (NCT07160933) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Development of a Psychosocial Intervention to Reduce Post Traumatic Stress in Young Adult Survivors of Cancer
United States80 participantsStarted 2026-04-15
Plain-language summary
The goal of this study is to develop a virtual group intervention to address post-traumatic stress related to cancer in young adult cancer survivors (YACs, aged 18-39). The study team will do this by integrating evidence-guided treatments and expert clinician feedback (N=10) on the content, delivery, and structure of the intervention. Next, the study team will refine this intervention through a pilot trial with a group of YACs (N=80).
Who can participate
Age range
18 Years – 39 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria: To be eligible for this study, participants will be:
* Currently aged between 18 - 39;
* Currently receiving or having completed treatment for cancer at the Mass General Cancer Institute within the past 5 years;
* Reporting a score denoting at least mild symptoms of PTSD on the Post-traumatic Stress Checklist 5 (PCL-5);
* English-speaking;
* Have access to a device with audio/video capabilities to complete virtual intervention sessions.
Exclusion Criteria:
* Unable to provide verbal consent
* Reporting active symptoms of psychosis that preclude safe participation.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Intervention Feasibility: Percent of Identified Prospective Participants Who Enroll
Timeframe: Post-treatment completion (enrollment to treatment completion is approximately 3 months)
2
Intervention Feasibility: Proportion of Participants Completing the Program
Timeframe: Post-treatment completion (enrollment to treatment completion is approximately 3 months)
3
Intervention Acceptability
Timeframe: Post-treatment completion (enrollment to treatment completion is approximately 3 months)